NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Clinical Study of MK-4482 in Chinese Healthy Male Participants (MK-4482-009)

CompletedPhase 1

Sponsor: Merck Sharp & Dohme LLC

Conditions: Healthy

Interventions: MK-4482

Countries: China

The goal of the study is to learn what happens to MK-4482 after single and multiple doses in healthy Chinese participants over time. Researchers also want to learn about the safety of MK-4482, including how well people tolerate it.

Eligibility overview

Sex: MALE

Age: 18 Years to 60 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

The main inclusion criteria include but are not limited to the following:

\- Has a Body Mass Index (BMI) of 19 to 24 weight (kg)/height (m)2, inclusive, and body weight of ≥ 50 kg at the screening visit.

Exclusion Criteria:

The main exclusion criteria include but are not limited to the following:

* Has a history of clinically significant abnormalities or diseases.
* Has history of cancer.
* Has a history of significant multiple and/or severe allergies.
* Had any major surgery.
* Has participated in another investigational study within 3 months prior to the screening visit.

Locations (1)

Beijing, Beijing Municipality, China